Invention Application
US20110288051A1 TRIAZOLOPYRIDINE 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
有权
三唑基吡啶11-羟基甾体脱氢酶I型抑制剂
- Patent Title: TRIAZOLOPYRIDINE 11-BETA HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORS
- Patent Title (中): 三唑基吡啶11-羟基甾体脱氢酶I型抑制剂
-
Application No.: US13197273Application Date: 2011-08-03
-
Publication No.: US20110288051A1Publication Date: 2011-11-24
- Inventor: Jun Li , Jeffrey A. Robl , James J. Li , Lawrence J. Kennedy , Haixia Wang , Jie Jack Li , Chenkou Wei , Michael Galella
- Applicant: Jun Li , Jeffrey A. Robl , James J. Li , Lawrence J. Kennedy , Haixia Wang , Jie Jack Li , Chenkou Wei , Michael Galella
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Main IPC: A61K31/695
- IPC: A61K31/695 ; C07F7/10 ; A61K31/437 ; A61P3/00 ; A61P5/08 ; A61P19/02 ; A61P27/06 ; A61P19/08 ; A61P3/10 ; A61P3/04 ; A61P3/06 ; A61P25/00 ; C07D471/02 ; A61P9/12
Abstract:
Novel compounds are provided which are 11-beta-hydroxysteroid dehydrogenase type I inhibitors. 11-beta-hydroxysteroid dehydrogenase type I inhibitors are useful in treating, preventing, or slowing the progression of diseases requiring 11-beta-hydroxysteroid dehydrogenase type I inhibitor therapy. These novel compounds of formula I: or stereoisomers or pharmaceutically acceptable salts thereof, wherein G, Q, X, Y, R3, R3a, and R3b are defined herein.
Public/Granted literature
- US08541444B2 Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors Public/Granted day:2013-09-24
Information query
